ARCA biopharma competitorsClear all

Verge Genomics's top competitors include Nightstar Therapeutics, Bioblast Pharma and Vical.
Verge Genomics
Verge Genomics
Verge Genomics specializes in human genomic data.
Nightstar Therapeutics
Nightstar Therapeutics
Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.
Bioblast Pharma
Bioblast Pharma
Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.
Vical
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Founding Date
Founding Date
2015
Founding Date
2013
Founding Date
2012
Founding Date
1987
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
San Francisco, US
Locations
London, GB HQ
Lexington, US
Locations
Tel Aviv-Yafo, IL HQ
Locations
San Diego, US HQ
Employees
Employees
288% increase
Employees
27
Employees
12
Employees
3059% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
853.8 m
Valuation ($)
603.6 k
Valuation ($)
18.9 m
Twitter followers
Twitter followers
1 k
Twitter followers
162
Twitter followers
N/A
Twitter followers
70
Alexa Website Rank
Alexa Website Rank
1097547
Alexa Website Rank
724942
Alexa Website Rank
2465558
Alexa Website Rank
1138819

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.6m (FY, 2018)
Net income
Net income
N/A
Net income
($12.2m) (FY, 2016)
Net income
($5.9m) (FY, 2017)
Net income
($16.3m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 36.1m
Total funding raised
$ 99.6m
Total funding raised
$ 4.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Nightstar Therapeutics
HQ
London, GB
Employees
27

Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.

View company
Bioblast Pharma
HQ
Tel Aviv-Yafo, IL
Employees
12

Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.

View company
Vical
HQ
San Diego, US
Employees
30

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

View company